Aida Pharmaceuticals, Inc. (AIDA)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Aug 5, 2025
Aida Pharmaceuticals Company Description
Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China.
It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment.
The company provides Etimicin Sulfate, an injectable powder form, as well as rh-Apo2l, a biopharmaceutical therapy for cancers.
Aida Pharmaceuticals, Inc. was founded in 1999 and is headquartered in Hangzhou, China.
Aida Pharmaceuticals, Inc.
| Country | United States |
| Founded | 1999 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 450 |
| CEO | Biao Jin |
Contact Details
Address: 31 Dingjiang Road Hangzhou, Nevada 310016 China | |
| Phone | 86 571 8580 2712 |
Stock Details
| Ticker Symbol | AIDA |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US0087211027 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Biao Jin | Chairman and Chief Executive Officer |
| Lin Hui | Chief Financial Officer and Principal Accounting Officer |
| Yue Jun Jiang | Chief of Investment Department and Secretary |
| Qiu Jiajun | Member of Compensation Committee and Director |